Pathological and Oncological Sciences II.
Aljomaa Seba
Centre for Translational Medicine
Seba Aljomaa1, Mark Hernadfoi1, Miklos Bartok1, Mira Szoke2, Tamas koi1, Reka Toth1, Miklos Garami1,3
1: Semmelweis university, Centre for Translational Medicine
2: Semmelweis university, Medical School
3: 2 Pediatric Center at Semmelweis University
Introduction: Digital health is an emerging approach in oncological care that can potentially improve health outcomes. The types of these interventions varied and were grouped under different categories, such as games, virtual reality (VR), mobile applications, and web-based platforms.
Aims: This study aimed to investigate the effect of these interventions on quality of life (QoL), anxiety, fatigue, and depression in cancer patients during active treatment by reviewing current published research.
Methods: Following PRISMA guidelines, a comprehensive literature search was performed to identify peer-reviewed journal articles that evaluated the use of digital health interventions, including games, virtual reality, mobile applications, and web-based platforms, among patients undergoing different cancer treatments. The search was conducted using PubMed, EMBASE, and the Cochrane Library.
Results: Changes in quality of life in mobile application groups compared to standard care controls across five analyzed studies improved the QoL of cancer patients significantly (SMD=0.36, CI [0.04, 0.68]). Our findings showed a positive effect of the VR, mobile applications, and web-based platforms on anxiety; no significant effects were found on fatigue or depression by using VR and web-based interventions.
Conclusion: Digital health interventions are promising tools to improve cancer
patients' mental and physical aspects during their treatment.
Funding: This study was funded by the Stipendium Hungaricum Scholarship and the SE 250+ Excellence PhD Scholarship Program